HEADER TRANSFERASE 26-NOV-03 1RLZ TITLE DEOXYHYPUSINE SYNTHASE HOLOENZYME IN ITS HIGH IONIC STRENGTH, LOW PH TITLE 2 CRYSTAL FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEOXYHYPUSINE SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DHS; COMPND 5 EC: 2.5.1.46; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DHPS, DS; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-11A KEYWDS ROSSMANN FOLD, NAD COFACTOR, DEOXYHYPUSINE, HYPUSINE, SPERMIDINE, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.C.UMLAND,E.C.WOLFF,M.-H.PARK,D.R.DAVIES REVDAT 5 23-AUG-23 1RLZ 1 REMARK REVDAT 4 12-NOV-14 1RLZ 1 KEYWDS REVDAT 3 13-JUL-11 1RLZ 1 VERSN REVDAT 2 24-FEB-09 1RLZ 1 VERSN REVDAT 1 13-JUL-04 1RLZ 0 JRNL AUTH T.C.UMLAND,E.C.WOLFF,M.-H.PARK,D.R.DAVIES JRNL TITL A NEW CRYSTAL STRUCTURE OF DEOXYHYPUSINE SYNTHASE REVEALS JRNL TITL 2 THE CONFIGURATION OF THE ACTIVE ENZYME AND OF AN JRNL TITL 3 ENZYME-NAD-INHIBITOR TERNARY COMPLEX JRNL REF J.BIOL.CHEM. V. 279 28697 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15100216 JRNL DOI 10.1074/JBC.M404095200 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.I.LIAO,E.C.WOLFF,M.-H.PARK,D.R.DAVIES REMARK 1 TITL CRYSTAL STRUCTURE OF THE NAD COMPLEX OF HUMAN DEOXYHYPUSINE REMARK 1 TITL 2 SYNTHASE: AN ENZYME WITH A BALL-AND-CHAIN MECHANISM FOR REMARK 1 TITL 3 BLOCKING THE ACTIVE SITE REMARK 1 REF STRUCTURE V. 6 23 1998 REMARK 1 REFN ISSN 0969-2126 REMARK 1 DOI 10.1016/S0969-2126(98)00004-5 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 22019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1295 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE : 0.2570 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 170 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.007 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2677 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 138 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.21 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1RLZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-DEC-03. REMARK 100 THE DEPOSITION ID IS D_1000020873. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22384 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 200 DATA REDUNDANCY : 4.660 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.35 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.17400 REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1DHS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7M SODIUM/POTASSIUM PHOSPHATE, 100MM REMARK 280 HEPES (PH 7.5), NAD, PH 4.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 4 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y+1/2,X+1/2,Z REMARK 290 4555 Y+1/2,-X+1/2,Z REMARK 290 5555 -X+1/2,Y+1/2,-Z REMARK 290 6555 X+1/2,-Y+1/2,-Z REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 54.30000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 54.30000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 54.30000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 54.30000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 54.30000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 54.30000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 54.30000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 54.30000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A TETRAMER GENERATED FROM THE REMARK 300 MONOMER IN THE ASYMMETRIC UNIT BY THE CRYSTALLOGRAPHIC OPERATIONS: - REMARK 300 Y, -X, 69.83-Z; -X, -Y, Z; AND Y, X, 69.83-Z REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 33120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41190 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -204.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 69.83000 REMARK 350 BIOMT1 4 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 69.83000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 LEU A 5 REMARK 465 GLU A 6 REMARK 465 ARG A 7 REMARK 465 GLU A 8 REMARK 465 PRO A 76 REMARK 465 LEU A 77 REMARK 465 SER A 78 REMARK 465 GLN A 79 REMARK 465 ASP A 80 REMARK 465 GLU A 81 REMARK 465 ASP A 82 REMARK 465 GLN A 83 REMARK 465 HIS A 84 REMARK 465 ALA A 85 REMARK 465 ASP A 86 REMARK 465 LEU A 87 REMARK 465 THR A 88 REMARK 465 GLN A 89 REMARK 465 SER A 90 REMARK 465 ARG A 91 REMARK 465 ARG A 92 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 54 -138.73 50.45 REMARK 500 SER A 233 80.71 -162.66 REMARK 500 GLN A 335 77.15 -116.08 REMARK 500 THR A 354 -90.72 -121.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DHS RELATED DB: PDB REMARK 900 EARLIER DEPOSITION OF SAME CRYSTAL FORM OBTAINED USING A DIFFERENT REMARK 900 DHS SAMPLE PREPARATION DBREF 1RLZ A 1 369 UNP P49366 DHYS_HUMAN 1 369 SEQRES 1 A 369 MET GLU GLY SER LEU GLU ARG GLU ALA PRO ALA GLY ALA SEQRES 2 A 369 LEU ALA ALA VAL LEU LYS HIS SER SER THR LEU PRO PRO SEQRES 3 A 369 GLU SER THR GLN VAL ARG GLY TYR ASP PHE ASN ARG GLY SEQRES 4 A 369 VAL ASN TYR ARG ALA LEU LEU GLU ALA PHE GLY THR THR SEQRES 5 A 369 GLY PHE GLN ALA THR ASN PHE GLY ARG ALA VAL GLN GLN SEQRES 6 A 369 VAL ASN ALA MET ILE GLU LYS LYS LEU GLU PRO LEU SER SEQRES 7 A 369 GLN ASP GLU ASP GLN HIS ALA ASP LEU THR GLN SER ARG SEQRES 8 A 369 ARG PRO LEU THR SER CYS THR ILE PHE LEU GLY TYR THR SEQRES 9 A 369 SER ASN LEU ILE SER SER GLY ILE ARG GLU THR ILE ARG SEQRES 10 A 369 TYR LEU VAL GLN HIS ASN MET VAL ASP VAL LEU VAL THR SEQRES 11 A 369 THR ALA GLY GLY VAL GLU GLU ASP LEU ILE LYS CYS LEU SEQRES 12 A 369 ALA PRO THR TYR LEU GLY GLU PHE SER LEU ARG GLY LYS SEQRES 13 A 369 GLU LEU ARG GLU ASN GLY ILE ASN ARG ILE GLY ASN LEU SEQRES 14 A 369 LEU VAL PRO ASN GLU ASN TYR CYS LYS PHE GLU ASP TRP SEQRES 15 A 369 LEU MET PRO ILE LEU ASP GLN MET VAL MET GLU GLN ASN SEQRES 16 A 369 THR GLU GLY VAL LYS TRP THR PRO SER LYS MET ILE ALA SEQRES 17 A 369 ARG LEU GLY LYS GLU ILE ASN ASN PRO GLU SER VAL TYR SEQRES 18 A 369 TYR TRP ALA GLN LYS ASN HIS ILE PRO VAL PHE SER PRO SEQRES 19 A 369 ALA LEU THR ASP GLY SER LEU GLY ASP MET ILE PHE PHE SEQRES 20 A 369 HIS SER TYR LYS ASN PRO GLY LEU VAL LEU ASP ILE VAL SEQRES 21 A 369 GLU ASP LEU ARG LEU ILE ASN THR GLN ALA ILE PHE ALA SEQRES 22 A 369 LYS CYS THR GLY MET ILE ILE LEU GLY GLY GLY VAL VAL SEQRES 23 A 369 LYS HIS HIS ILE ALA ASN ALA ASN LEU MET ARG ASN GLY SEQRES 24 A 369 ALA ASP TYR ALA VAL TYR ILE ASN THR ALA GLN GLU PHE SEQRES 25 A 369 ASP GLY SER ASP SER GLY ALA ARG PRO ASP GLU ALA VAL SEQRES 26 A 369 SER TRP GLY LYS ILE ARG VAL ASP ALA GLN PRO VAL LYS SEQRES 27 A 369 VAL TYR ALA ASP ALA SER LEU VAL PHE PRO LEU LEU VAL SEQRES 28 A 369 ALA GLU THR PHE ALA GLN LYS MET ASP ALA PHE MET HIS SEQRES 29 A 369 GLU LYS ASN GLU ASP HET NAD A 700 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 2 NAD C21 H27 N7 O14 P2 FORMUL 3 HOH *138(H2 O) HELIX 1 1 PRO A 10 LEU A 18 1 9 HELIX 2 2 ASP A 35 GLY A 39 5 5 HELIX 3 3 ASN A 41 ALA A 48 1 8 HELIX 4 4 PHE A 49 THR A 52 5 4 HELIX 5 5 GLY A 53 LEU A 74 1 22 HELIX 6 6 SER A 105 SER A 110 1 6 HELIX 7 7 GLY A 111 HIS A 122 1 12 HELIX 8 8 THR A 131 LYS A 141 1 11 HELIX 9 9 ARG A 154 ASN A 161 1 8 HELIX 10 10 ASN A 173 GLU A 197 1 25 HELIX 11 11 THR A 202 ASN A 215 1 14 HELIX 12 12 SER A 219 ASN A 227 1 9 HELIX 13 13 GLY A 239 ASN A 252 1 14 HELIX 14 14 ILE A 259 PHE A 272 1 14 HELIX 15 15 GLY A 283 MET A 296 1 14 HELIX 16 16 ARG A 320 GLY A 328 1 9 HELIX 17 17 ASP A 342 THR A 354 1 13 HELIX 18 18 PHE A 355 GLN A 357 5 3 HELIX 19 19 LYS A 358 LYS A 366 1 9 SHEET 1 A 6 VAL A 231 PHE A 232 0 SHEET 2 A 6 VAL A 127 THR A 130 1 N LEU A 128 O PHE A 232 SHEET 3 A 6 THR A 98 TYR A 103 1 N LEU A 101 O VAL A 127 SHEET 4 A 6 THR A 276 LEU A 281 1 O LEU A 281 N GLY A 102 SHEET 5 A 6 TYR A 302 ASN A 307 1 O VAL A 304 N MET A 278 SHEET 6 A 6 VAL A 337 TYR A 340 1 O VAL A 339 N TYR A 305 SHEET 1 B 3 TYR A 147 LEU A 148 0 SHEET 2 B 3 LEU A 169 PRO A 172 -1 O LEU A 170 N TYR A 147 SHEET 3 B 3 ILE A 163 ILE A 166 -1 N ILE A 166 O LEU A 169 SITE 1 AC1 28 THR A 104 SER A 105 ASN A 106 LEU A 107 SITE 2 AC1 28 SER A 109 THR A 131 ALA A 132 GLY A 133 SITE 3 AC1 28 GLU A 137 ASP A 238 GLY A 282 GLY A 283 SITE 4 AC1 28 GLY A 284 VAL A 285 HIS A 288 ILE A 306 SITE 5 AC1 28 ASN A 307 THR A 308 ALA A 309 ASP A 313 SITE 6 AC1 28 SER A 315 ASP A 316 SER A 317 ALA A 341 SITE 7 AC1 28 ASP A 342 ALA A 343 HOH A 702 HOH A 707 CRYST1 108.600 108.600 69.830 90.00 90.00 90.00 P 4 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009208 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014320 0.00000